Skip to main content

Amgen & Abbvie Increase the Price of TNF Inhibitors

The manufacturers of the 2 best selling TNF inhibitors, Enbrel and Humira, have announced a 9.9% price increase of May 1st. The current average price of Enbrel is $42,000 per annum.

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

Disclosures
The author has received research/grant financial support on this subject
The author has received compensation as an advisor or consultant on this subject